期刊文献+

乳腺癌中p73α和p53表达与化疗药物敏感性的关系

Relationship between expression of p73α and p53 and chemosensitivity in breast cancer
下载PDF
导出
摘要 目的:研究乳腺癌细胞p73α、p53表达与化疗药物敏感性的关系.方法:选取病理诊断为乳腺癌(术前未行放疗、化疗)的手术切除标本12例,体外分离细胞作培养,应用四甲基偶氮唑盐(MTT)法分析表阿霉素(EPI)、丝裂霉素(MMC)、5-氟脲嘧啶(5-FU)、顺铂(DDP)4种化疗药物对乳腺癌细胞的相对抑制率,通过免疫细胞化学染色法分析乳腺癌细胞p73α、p53的表达.结果:0.1×PPC浓度时乳腺癌细胞对4种化疗药物的敏感率分别为MMC(42%)、EPI(33%)、5-Fu(17%)、DDP(17%);p73α(+)的乳腺癌细胞对4种化疗药物敏感性均高于p73α(-)的乳腺癌细胞(P<0.05),p73α阳性表达程度与乳腺癌细胞对EPI、MMC、5-Fu、DDP4种化疗药物的敏感性存在正相关关系(r=0.736,P<0.05;r=0.744,P<0.05;r=0.674,P<0.05;r=0.721,P<0.05).结论:p73α的表达与乳腺癌细胞对化疗药物敏感性有关. AIM: To investigate the relationship between the expression of p73a and p53 in breast cancer cells and chemosensitivity. METHODS: Twelve surgical samples of pathologically diagnosed breast cancer were used. The cancer cells were isolated and cultured in the incubator at 37℃, 50 mL/L CO2 in vitro. The inhibitory rates of cancer cells by 4 kinds of anticancer drugs (EPI, MMC, 5-FU and DDP) were assayed by MTT method. Immunocytochemistry was used to detect the expression of p73α and p53 in the cancer cells. RESULTS: The sensitivity of the 12 breast cancer cells in 0. 1 x PPC within 72 h in vitro was 42% (MMC), 33 % (EPI) and 17% (both 5-FU and DDP). The inhibitory rates of MMC, EPI, 5-FU and DDP were significantly higher in p73α positive cancer cells than in p73a negative cancer cells. A positive correlation was found between the expression of p73a and chemosensitivity in all the four anticancer drugs. CONCLUSION: The expression of p73a is related to the chemosensitivity of the breast cancer cells and it can be used as one of the markers for clinical assessment of the effect of chemotherapy.
作者 周鑫 孙治君
出处 《第四军医大学学报》 北大核心 2005年第16期1517-1519,共3页 Journal of the Fourth Military Medical University
关键词 乳腺肿瘤 基因 p73α 基因 p53 化疗敏感性 breast neoplasms genes, p73α genes, p53 chemosensitivity
  • 相关文献

参考文献6

  • 1Weber A, Bellmann U, Bootz F, et al. Expression of p53 and its homologues in primary and recurrent squamous cell carcinomas of the head and neck[J] . Int J Cancer, 2002; 99(1) : 22 -28.
  • 2Gong JG, Costanzo A, Yang HQ, et al. The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage[J]. Nature, 1999; 399(6738) : 806-809.
  • 3Truong T, Sun G, Doorly M, et al. Modulation of DNA damage -induced apoptosis by cell adhesion is independentedly mediated by p53and c-Abl [ J ]. Proc Natl Acad Sci U S A, 2003; 100 ( 18 ): 10281- 10286.
  • 4Zhu J, Nozell S, Wang J, et al. P73 cooperates with DNA damage agents to induce apoptosis in MCF7 cells in a p53-dependent manner[J] . Oncogene, 2000; 20(30): 4050 -4057.
  • 5何勇,范士志,蒋耀光,陈建明,李志平,周萍,周元国.p73基因对人肺腺癌细胞H1299化疗敏感性的影响[J].癌症,2004,23(6):645-649. 被引量:11
  • 6Kim R, Ohi Y, Inoue H, et al. Taxotere activates transcription factor AP-1 in assiciation with apoptotic cell death in gastric cancer celllines[J]. Anticancer Res, 1999; 19(6B):5399-5405.

二级参考文献7

  • 1Schuler M, Rochlitz C, Horowitz JA, et al. A phase Ⅰ study of adenovirus-mediated p53 gene transfer in patients with advanced non-small cell lung cancer [J] . Hum Gene Ther, 1998, 9( 14):2075 - 2082.
  • 2Dorigo O, Turla ST, Lebedeva S, et al. Sensitization of rat glioblastoma multiforme to cisplatin in vivo following restoration of wild-type p53 function [J] . J Neurosurg, 1998, 88(3): 535 -540.
  • 3Inoue A, Narumi K, Matsubara N, et al. Administration of wild-type p53 adenoviral vector synergistically enhances the cytotoxicity of anti-cancer drug in human lung cancer cells irrespective of the status of p53 gene [J]. Cancer Lett, 2000, 157(1): 105-112.
  • 4Nemunaitis J, Swisher SG, Timmons T, et al. Adenovirus-mediated p53 gene transfer in sequence with cisplatin to tumors of patients with non-small-cell lung cancer [J]. J Clin Oncol, 2000, 18(3):609 - 622.
  • 5Miyake H, Hara I, Hara S, et al. Synergistic chemosensitization and inhibition of tumor growth and metastasis by adenovirusmediated p53 gene transfer in human bladder cancer model [J].Urology, 2000, 56(2): 332 - 336.
  • 6Agami R, Bernards R. Distinct initiation and maintenance mechanisms cooperate to induce Gl cell cycle arrest in response to DNA damage [ J ]. Cell, 2000, 102 ( 1 ): 55 - 66.
  • 7Brown JM. NCI's anticancer drug screening program may not be selecting for clinically active compounds [J]. Oncol Res, 1997, 9(5):213 -215.

共引文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部